Kristen Buck previously served as the Executive Vice President of Research and Development and Chief Medical Officer at Caladrius Biosciences.
Kristen Buck previously served as the Executive Vice President of Research and Development and Chief Medical Officer at Caladrius Biosciences. She was involved in communications regarding the definitive merger agreement between Caladrius Biosciences and Cend Therapeutics, which led to the formation of Lisata Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library